A3AR is unique in its expression pattern, as under normal physiological conditions, it has low expression levels; however, in cancer and inflammation, its expression level increases in the disease target organ and the peripheral blood mononuclear cells (PBMCs) of the patients [7,8,9]. Here, ADORA3 is linked to cancer.